Лечение коагулопатии, связанной с большим акушерским кровотечением: описательный обзор
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.482
Аннотация
Акушерские кровотечения представляют собой одну из основных причин материнской смертности во всем мире. Вместе с гипертензивными расстройствами они составляют более половины случаев материнской смертности. Внедрение стратегий, таких как «красный код», увеличение числа институциональных родов, ранние трансфузии и системы раннего предупреждения в акушерстве, привело к снижению смертности. Случаи массивного кровотечения требуют госпитализации в отделение интенсивной терапии, так как они могут усугубляться вплоть до развития коагулопатии. Настоящий описательный обзор фокусируется на лекарствах, предназначенных для более эффективного ведения коагулопатией в указанной группе лиц.
Об авторах
Л. Корреа-Перес
Университет Росарио; Педиатрическая клиника Colsanitas y Mujer
Колумбия
Колумбия
Корреа-Перес Лилиана, магистр по биоэтике, магистр общественного здравоохранения
Scopus Author ID: 57202113479
6-25 ул. 12C, Богота, округ Колумбия
20-56 ул. 127, Богота 110911
С. Олайя-Гарай
Университет Манисалеса
Колумбия
Колумбия
Олайя-Гарай Сандра
Scopus Author ID: 55293174800
ул. 9а. № 19-03, Манисалес 170001
С. Мора-Мартинес
Университет Манисалеса; Корпорация Universitaria Empresarial Александра фон Гумбольдта
Россия
Россия
Мора-Мартинес Сантьяго
Scopus Author ID:57217172045
ул. 9а. № 19-03, Манисалес 170001
15 Северная – 46 ул. 13, Армения 630008
Список литературы
1. Douthard R.A., Martin I.K., Chapple-McGruder T. et al. U.S. maternal mortality within a global context: historical trends, current state, and future directions. J Womens Health (Larchmt). 2021;30(2):168–77. https://doi.org/10.1089/jwh.2020.8863.
2. The WHO application of ICD-10 to deaths during pregnancy, childbirth, and the puerperium: ICD-MM. World Health Organization, 2013. 38 p. Available at: https://www.hsph.harvard.edu/wp-content/uploads/sites/2413/2014/05/Doris-Chou.pdf. [Accessed: 15.01.2024].
3. Trikha A., Singh P.M. Management of major obstetric haemorrhage. Indian J Anaesth. 2018;62(9):698–703. https://doi.org/10.4103/ija.IJA_448_18.
4. Dahlke J.D., Mendez-Figueroa H., Maggio L. et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol. 2015;213(1):76.e1–76.e10. https://doi.org/10.1016/j.ajog.2015.02.023.
5. Vélez-Álvarez G.A., Agudelo-Jaramillo B., Gómez-Dávila J.G., ZuletaTobón J.J. Code Red: guide for the management of obstetric bleeding. Rev Colomb Obstet Ginecol. 2009;60(1):34–48. https://doi.org/10.18597/rcog.352.
6. Robinson D., Basso M., Chan C. et al. Guideline No. 431: postpartum hemorrhage and hemorrhagic shock. J Obstet Gynaecol Can. 2022;44(12):1293–1310.e1. https://doi.org/10.1016/j.jogc.2022.10.002.
7. Shakur H., Elbourne D., Gülmezoglu M. et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40. https://doi.org/10.1186/17456215-11-40.
8. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with postpartum haemorrhage (WOMAN): an international, randomised, double- blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16. https://doi.org/10.1016/S0140-6736(17)30638-4.
9. Muñoz M., Stensballe J., Ducloy-Bouthors A.S. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 2019;17(2):112–36. https://doi.org/10.2450/2019.0245-18.
10. Reale S.C., Farber M.K. Point-of-care coagulation testing for obstetric hemorrhage: time for a theranostic approach? Int J Obstet Anesth. 2019;38:1–3. https://doi.org/10.1016/j.ijoa.2019.04.001.
11. Abdul-Kadir R., McLintock C., Ducloy A.S. et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54(7):1756–68. https://doi.org/10.1111/trf.12550.
12. Bell S.F., Kitchen T., John M. et al. Designing and implementing an all Wales postpartum haemorrhage quality improvement project: OBS Cymru (the Obstetric Bleeding Strategy for Wales). BMJ Open Qual. 2020;9(2):e000854. https://doi.org/10.1136/bmjoq-2019-000854.
13. Collins P.W., Bell S.F., de Lloyd L., Collis R.E. Management of postpartum haemorrhage: from research into practice, a narrative review of the literature and the Cardiff experience. Int J Obstet Anesth. 2019;37:106– 17. https://doi.org/10.1016/j.ijoa.2018.08.008.
14. Muñoz M., Peña-Rosas J.P., Robinson S. et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018;28(1):22–39. https://doi.org/10.1111/tme.12443.
15. Franchini M., Liumbruno G.M. Implementation of a patient blood management programme in obstetrics: let's do it! Blood Transfus. 2019;17(2):87–8. https://doi.org/10.2450/2019.0269-18.
16. Katz D., Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth. 2015;115 Suppl 2:ii75–88. https://doi.org/10.1093/bja/aev374.
17. de Lange N.M., Lancé M.D., de Groot R. et al. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv. 2012;67(7):426–35. https://doi.org/10.1097/OGX.0b013e3182605861.
18. Nester T. Transfusion management of the obstetrical patient: a clinical casebook. Ed. T. Nester. Springer, USA. 2018. 246 р.
19. Collis R.E., Collins P.W. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015;70 Suppl 1:78–86, e27–8. https://doi.org/10.1111/anae.
20. Cortet M., Deneux-Tharaux C., Dupont C. et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984–9. https://doi.org/10.1093/bja/aes096.
21. Charbit B., Mandelbrot L., Samain E. et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266–73. https://doi.org/10.1111/j.1538-7836.2007.02297.x.
22. de Lloyd L., Bovington R., Kaye A. et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20(2):135–41. https://doi.org/10.1016/j.ijoa.2010.12.002.
23. Wikkelsoe A.J., Afshari A., Stensballe J. et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2012;13:110. https://doi.org/10.1186/1745-6215-13-110.
24. Ducloy-Bouthors A.S., Mignon A., Huissoud C. et al. Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced coagulopathy: A study protocol for a randomised multicentre controlled trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial. Anaesth Crit Care Pain Med. 2016;35(4):293–8. https://doi.org/10.1016/j.accpm.2015.10.011.
25. Ducloy-Bouthors A.S., Mercier F.J., Grouin J.M. et al.; FIDEL working group. Early and systematic administration of fibrinogen concentrate in postpartum haemorrhage following vaginal delivery: the FIDEL randomised controlled trial. BJOG. 2021;128(11):1814–23. https://doi.org/10.1111/1471-0528.16699.
26. Mallaiah S., Barclay P., Harrod I. et al. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70(2):166–75. https://doi.org/10.1111/anae.12859.
27. Collins P.W., Cannings-John R., Bruynseels D. et al. Viscoelastometryguided fresh frozen plasma infusion for postpartum haemorrhage: OBS2, an observational study. Br J Anaesth. 2017;119(3):422–34. https://doi.org/10.1093/bja/aex245.
28. Collins P.W., Cannings-John R., Bruynseels D. et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth. 2017;119(3):411–21. https://doi.org/10.1093/bja/aex181.
29. Guasch E., Alsina E., Díez J. et al. Postpartum hemorrhage: an observational study of 21,726 deliveries in 28 months. Rev Esp Anestesiol Reanim. 2009;56(3):139–46. (In Spanish). https://doi.org/10.1016/s0034-9356(09)70356-1.
30. Belpiede A., Tinelli A., Crescini C. et al. Post-partum hemorrhage: can it be prevented by assisting the natural physiological process? Ital J Gynaecol Obstet. 2021;33(2):110–19. https://doi.org/10.36129/jog.33.02.05.
31. Saccone G., Nazzaro G., Miranda M. et al. Use of tranexamic acid at the time of delivery. Ital J Gynaecol Obstet. 2024;36(1):70–6. https://doi.org/10.36129/jog.2023.107.
Рецензия
Для цитирования:
Корреа-Перес Л., Олайя-Гарай С., Мора-Мартинес С. Лечение коагулопатии, связанной с большим акушерским кровотечением: описательный обзор. Акушерство, Гинекология и Репродукция. 2025;19(6):914–922. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.482
For citation:
Correa-Pérez L., Olaya-Garay S., Mora-Martínez S. Management of coagulopathy related to major obstetric bleeding: narrative review. Obstetrics, Gynecology and Reproduction. 2025;19(6):914–922. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.482
Просмотров:
52
JATS XML
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Послать статью по эл. почте 